0001209191-22-013765.txt : 20220228
0001209191-22-013765.hdr.sgml : 20220228
20220228184625
ACCESSION NUMBER: 0001209191-22-013765
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220224
FILED AS OF DATE: 20220228
DATE AS OF CHANGE: 20220228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Quintana Marie
CENTRAL INDEX KEY: 0001769891
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07293
FILM NUMBER: 22692664
MAIL ADDRESS:
STREET 1: 14201 DALLAS PARKWAY
CITY: DALLAS
STATE: TX
ZIP: 75254
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TENET HEALTHCARE CORP
CENTRAL INDEX KEY: 0000070318
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
IRS NUMBER: 952557091
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 14201 DALLAS PARKWAY
CITY: DALLAS
STATE: TX
ZIP: 75254
BUSINESS PHONE: 469-893-2200
MAIL ADDRESS:
STREET 1: 14201 DALLAS PARKWAY
CITY: DALLAS
STATE: TX
ZIP: 75254
FORMER COMPANY:
FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-24
0
0000070318
TENET HEALTHCARE CORP
THC
0001769891
Quintana Marie
14201 DALLAS PARKWAY
DALLAS
TX
75254
0
1
0
0
EVP, Marketing/Communications
Common Stock
2022-02-24
4
M
0
2680
A
4979
D
Common Stock
2022-02-24
4
F
0
695
81.20
D
4284
D
Common Stock
2022-02-25
4
M
0
5096
A
9380
D
Common Stock
2022-02-25
4
F
0
1241
85.71
D
8139
D
Common Stock
2022-02-25
4
M
0
2753
A
10892
D
Common Stock
2022-02-25
4
F
0
671
85.71
D
10221
D
2021 February Restricted Stock Units
2022-02-24
4
M
0
2680
0.00
D
Common Stock
2680
5362
D
2020 February Restricted Stock Units
2022-02-25
4
M
0
5096
0.00
D
Common Stock
5096
5096
D
2019 February Restricted Stock Units
2022-02-25
4
M
0
2753
0.00
D
Common Stock
2753
0
D
As previously reported, on February 24, 2021, the reporting person received a grant of 8,042 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 24, 2022, resulting in the vesting and settlement of 2,680 shares of common stock, as shown in Table I. The remaining 5,362 restricted stock units are shown in Table II, of which 2,681 are scheduled to vest on each of February 24, 2023, and February 24, 2024.
Restricted stock units convert into common stock on a one-for-one basis.
Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
As previously reported, on February 26, 2020, the reporting person received a grant of 15,288 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 5,096 shares of common stock. The second anniversary occurred on February 25, 2022 (the business day prior to February 26, 2022, which fell on a weekend), resulting in the vesting and settlement of 5,096 shares of common stock, as shown in Table I. The remaining 5,096 restricted stock units are shown in Table II, and are scheduled to vest on February 26, 2023.
As previously reported, on February 27, 2019, the reporting person received a grant of 8,257 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 2,752 shares of common stock. The second anniversary occurred on February 26, 2021 (the business day prior to February 27, 2021, which fell on a weekend), resulting in the vesting and settlement of 2,752 shares of common stock. The third anniversary occurred on February 25, 2022 (the business day prior to February 27, 2022, which fell on a weekend), resulting in the vesting and settlement of 2,753 shares of common stock, as shown in Table I.
Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.
Chad J. Wiener, as Attorney-in-Fact for Marie Quintana
2022-02-28